Non-O Blood Type May Increase VTE Risk in Patients With Cancer

Recommended

Study Finds Racial Disparities in Cancer-Associated Thrombosis

Early Treatment of Rituximab Combined With Eltrombopag for Secondary Thrombocytopenic Purpura in Rheumatoid Arthritis

cITP Associated With Familial Autoimmune Dysregulation

SDF-1α Facilitates Mesenchymal Stem Cells to Induce Regulatory B Cell Differentiation from Patients With Immune Thrombocytopenia

Quantitative LC–MS/MS Uncovers the Regulatory Role of Autophagy in Immune Thrombocytopenia

Unexpected Thrombocytosis Could Flag Occult Cancer

Effectiveness of Corticosteroids in the Treatment of Chemotherapy-Induced Thrombocytopenia

Non-O Blood Type May Increase VTE Risk in Patients With Cancer

header-info

Apr, 27, 2022

New findings suggest that patients with cancer who have non-O blood types (types A, B, and AB) have a higher risk of developing VTEs at 3 months or more after their initial cancer diagnosis.